Press Releases - WDM Group PR Network  

Tobacco Interests Spent Nearly $137 Million In The Past Year To Influence Legislative Policy And Elections In California

The American Lung Association in California's Center for Tobacco Policy & Organizing releases a new report on campaign contributions and lobbying expenditures by tobacco interests during the 2011-2012 election cycle SACRAMENTO, Calif., Sept. 26, 2012 /PRNewswire-USNewswire/ -- Tobacco interests spent a...

Patient-Centered Outcomes Research Institute Seeks Specific Research Questions from Patients and Stakeholders

PCORI Opens Web Survey to Receive Suggestions for Research Topics Directly from the Health Care Community WASHINGTON, Sept. 26, 2012 /PRNewswire-USNewswire/ -- The Patient-Centered Outcomes Research Institute (PCORI) is now offering patients, caregivers and the broader health care community...

Statement by Americans for Nonsmokers' Rights: Electronic (e)-cigarette manufacturers shamelessly promote untested product for use in "smokefree" environments; make false claims about efficacy as cessation device too

BERKELEY, Calif., Sept. 26, 2012 /PRNewswire-USNewswire/ -- Proponents of electronic cigarettes, commonly known as "e-cigarettes," are misleading the public about these products through paid press releases, advertorials, and online social media by making unsubstantiated claims about their benefits and offering...

Giant Food alerts customers to voluntary recall of Sunland Peanut Butter Products

LANDOVER, Md., Sept. 26, 2012 /PRNewswire/ -- Giant Food of Landover, Md., following a recall by Sunland Inc. announced it removed from sale select varieties of peanut butter products due to possible salmonella contamination. The following products, with best if used...

Accera, Inc. to Support the Alzheimer's Foundation of America's (AFA) National Memory Screening Day (NMSD)

BROOMFIELD, Colo., Sept. 26, 2012 /PRNewswire/ -- Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical applications to address acute and chronic neurodegenerative diseases, announced today that it is a silver sponsor of...

OrthoAccel® Technologies, Inc. Receives Clearance from Korean Food and Drug Administration for AcceleDent™

HOUSTON, Sept. 26, 2012 /PRNewswire/ -- OrthoAccel™ Technologies has just received official clearance from the Korean Food and Drug Administration (KFDA) to begin commercial sales of its AcceleDent™ orthodontic device in South Korea. "I'm extremely gratified by this news," says...

Planned Parenthood Urges Women Under 40 To Take Control Of Their Health During National Breast Cancer Awareness Month

NEW YORK, Sept. 26, 2012 /PRNewswire-USNewswire/ -- Planned Parenthood, the nation's leading women's health care provider and advocate, is encouraging women under 40 to take control of their breast health during National Breast Cancer Awareness Month.    "Early detection saves lives,"...

Elsevier Launches New Open Access Journal - NeuroImage: Clinical

LONDON, September 26, 2012 /PRNewswire/ -- Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces the launch of NeuroImage: Clinical, a new open access journal, and sister journal to NeuroImage. NeuroImage: Clinical provides a vehicle...

West Health Institute Unveils New Kinect-based Physical Therapy Technology, Launches Research Studies with Naval Medical Center San Diego

Innovative System Could Lower Costs of Musculoskeletal Disease by Improving Rehabilitation Adherence and Outcomes SAN DIEGO, Sept. 26, 2012 /PRNewswire-USNewswire/ -- The West Health Institute announced it has developed technology that could revolutionize physical therapy using Microsoft's Kinect for Windows cutting-edge,...

Frederic Chereau Joins Shire Human Genetic Therapies to Lead Angioedema Franchise

LEXINGTON, Mass., Sept. 26, 2012 /PRNewswire/ -- Shire plc (LSE: SHP; NASDAQ: SHPG), today announced the appointment of Frederic Chereau as Senior Vice President and Franchise Lead, Angioedema, for its Human Genetic Therapies (HGT) business. In this role, Frederic will oversee...
| ... 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | 104 | 105 | 106 | 107 | 108 | 109 | 110 | 111 | 112 | 113 | 114 | 115 | 116 | 117 | 118 | 119 | 120 | 121 | 122 | 123 | 124 | 125 | 126 | 127 | 128 | 129 | 130 | 131 | 132 | 133 | 134 | 135 | 136 | 137 | 138 | 139 | 140 | 141 | 142 | 143 | 144 | 145 | 146 | 147 | 148 | 149 | 150 | 151 | 152 | 153 | 154 | 155 | 156 | 157 | 158 | 159 | 160 | 161 | 162 | 163 | 164 | 165 | 166 | 167 | 168 | 169 | 170 | 171 | 172 | 173 | 174 | 175 | 176 | 177 | 178 | 179 | 180 | 181 | 182 | 183 | 184 | 185 | 186 | 187 | 188 | 189 | 190 | 191 | 192 | ...


Featured Articles + MORE Featured Articles >>